Enhancement of immunohistochemical reactivity for thymidine phosphorylase in breast carcinoma cells after administration of docetaxel as a neoadjuvant chemotherapy in advanced breast cancer patients.
Masafumi Kurosumi(Saitama Cancer Center), Yujiro Higashi(The University of Osaka), Toshio Tabei(Saitama Cancer Center), Noritaka Sugamata(Saitama Cancer Center), Kimito Suemasu(Saitama Cancer Center), Kenichi Inoue(Universitair Ziekenhuis Leuven), T Kusawake(Saitama Cancer Center)
Cited by 54
Related Papers
MONARCH 2: Abemaciclib in Combination With Fulvestrant in Women With HR+/HER2− Advanced Breast Cancer Who Had Progressed While Receiving Endocrine Therapy
|Journal of Clinical Oncology|2017|1.7k
The Effect of Abemaciclib Plus Fulvestrant on Overall Survival in Hormone Receptor–Positive, ERBB2-Negative Breast Cancer That Progressed on Endocrine Therapy—MONARCH 2
|JAMA Oncology|2019|983
Mice Lacking Zfhx1b, the Gene That Codes for Smad-Interacting Protein-1, Reveal a Role for Multiple Neural Crest Cell Defects in the Etiology of Hirschsprung Disease–Mental Retardation Syndrome
|The American Journal of Human Genetics|2003|308
Zeb1 links epithelial-mesenchymal transition and cellular senescence
|Development|2008|302